Chemical Compound

iohexol

CAS Registry Number 66108-95-0
iohexol chemical structure
Primary Record

iohexol

In stock
5,846 g
Purity
98.5 %
CAS
66108-95-0

Compound Identifiers & Properties

CAS
66108-95-0
PubChem CID
3730
SMILES
CC(=O)N(CC(CO)O)C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I
Canonical SMILES
CC(=O)N(CC(O)CO)c1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)NCC(O)CO)c1I

Names & Synonyms

  • iohexol
  • Omnipaque
  • Exypaque
  • Nycodenz
  • Iohexolum
  • 66108-95-0
  • Histodenz
  • Omnipaque 240
  • Oraltag
  • Omnipaque 140
  • Omnipaque 300
  • Omnipaque 350
  • Accudenz
  • Omnipaque 70
  • Omnipaque 180
  • Omnipaque 210
  • ioexolo
  • ioxilan
  • Imagenil
  • Imaginil
  • Moiopaque
  • Omnepaque
  • Iopaque
  • Ioverin
  • Oxilan
  • Iosol
  • Oxilan iohexol
  • Histodenz™
  • Iohexol CRS
  • Iohexol-d5
  • Iohexol 350
  • Omnipaque (TN)
  • Iohexolum [INN-Latin]
  • Prestwick_802
  • Iohexol (Standard)
  • Compound 545
  • Imagenil 300
  • Imagenil 350
  • Histodenz|||Nycodenz
  • OMNIPAQUE 9
  • IOHEXOL [VANDF]
  • RefChem:57667
  • DTXSID6023157
  • IOHEXOL [USAN]
  • IOHEXOL [INN]
  • IOHEXOL [JAN]
  • WIN 39424
  • WIN-39424
  • AC1L1GKZ
  • IOHEXOL [MI]
  • OMNIPAQUE 12
  • IOHEXOL [MART.]
  • Prestwick0_000512
  • Prestwick1_000512
  • Prestwick2_000512
  • Prestwick3_000512
  • GlyTouCan:G94717WG
  • NTHXOOBQLCIOLC-UHFFFAOYSA-N
  • IOHEXOL [USP-RS]
  • IOHEXOL [WHO-DD]
  • IOHEXOL [WHO-IP]
  • CHEBI:31709
  • D02BLO
  • Nycodenz;Omnipaque;Exypaque
  • C19H26I3N3O9
  • DTXCID803157
  • Iohexol, analytical standard
  • MFCD00077732
  • SCHEMBL26501
  • BSPBio_000463
  • UNII-4419T9MX03
  • Iohexol [USAN:BAN:INN:JAN]
  • MLS001332585
  • MLS001332586
  • MLS002153854
  • Iohexol (JP18/USP/INN)
  • IOHEXOL [EP IMPURITY]
  • IOHEXOL [ORANGE BOOK]
  • EINECS 266-164-2
  • SPBio_002384
  • IOHEXOL [EP MONOGRAPH]
  • BPBio1_000511
  • orb1308214
  • IOHEXOL [USP MONOGRAPH]
  • 4419T9MX03
  • CHEMBL1200455
  • NSC-759636
  • BCBcMAP01_000051
  • CTK8G0334
  • HY-B0594R
  • Iohexol [USAN:INN:BAN:JAN]
  • BRN 2406632
  • CID3730
  • IOHEXOLUM [WHO-IP LATIN]
  • V08AB02
  • C17H22I3N3O8
  • Iohexol [USAN:USP:INN:BAN:JAN]
  • Iohexol; Iodixanol EP Impurity A
  • HMS1569H05
  • HMS2096H05
  • HMS2235D07
  • HMS3369O04
  • HMS3713H05
  • HMS5086H14
  • HMS6018F09
  • ALBB-028959
  • AMY21804
  • BCP31800
  • CID:3730
  • DMB62333
  • EBD45459
  • G94717WG
  • HY-B0594
  • Iohexol for peak identification CRS
  • KS-00001F7T
  • MSK11045
  • Tox21_112286
  • BDBM50247977
  • EBC-27484
  • IOHEXOL (MIXTURE OF ISOMERS)
  • NCGC00166000-01
  • s4531
  • AKOS015895399
  • Iodixanol EP Impurity A (Free Base)
  • Tox21_112286_1
  • AC-1934
  • C19-H26-I3-N3-O9
  • CCG-220512
  • CS-2811
  • DB01362
  • FI24632
  • NSC 759636
  • SMP1_000152
  • NCGC00166000-02
  • NCGC00166000-04
  • AN-14471
  • AS-12699
  • BC209326
  • J18.922G
  • LS-29715
  • SC-17734
  • SMR000857075
  • EC 266-164-2
  • SID:134222686
  • AB0012347
  • CAS-66108-95-0
  • FT-0627276
  • I0903
  • N,N'-Bis(2,3-dihydroxypropyl)-5-(N-(2,3-dihydroxypropyl)acetamido)-2,4,6-triiodoisophthalamide
  • NS00000223
  • D01817
  • D91214
  • Histodenz(TM), nonionic density gradient medium
  • N1,N3-bis(2,3-dihydroxypropyl)-5-(N-(2,3-dihydroxypropyl)acetamido)-2,4,6-triiodoisophthalamide
  • 108I950
  • A835339
  • D007472
  • EN300-19628570
  • F862815
  • Q410683
  • SR-01000838892
  • 5-[acetyl(2,3-dihydroxypropyl)amino]-1-N,3-N-bis(2,3-dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide
  • I06-0659
  • SR-01000838892-2
  • 5-(N-2,3-Dihydroxypropylacetamido)-2,4,6-triiodo-N,N'-bis(2,3-dihydroxypropyl)isophthalamide
  • 5-[Acetyl(2,3-dihydroxypropyl)amino]-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamide
  • BRD-A60217728-001-11-2
  • 1,3-Benzenedicarboxamide, 5-(acetyl(2,3-dihydroxypropyl)amino)-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-
  • Iohexol, European Pharmacopoeia (EP) Reference Standard
  • Iohexol, United States Pharmacopeia (USP) Reference Standard
  • N1,N3-bis(2,3-dihydroxypropyl)-5-[N-(2,3-dihydroxypropyl)acetamido]-2,4,6-triiodobenzene-1,3-dicarboxamide
  • 5-(N-dhp-acetamido)-2,4,6-triiodo-N,N'-B is-dhp-isophthalami
  • 1,3-benzenedicarboxamide, 5-[acetyl(2,3-dihydroxypropyl)amino]-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-
  • 1,3-Benzenedicarboxamide, 5-[acetyl(2,3-dihydroxypropyl)amino]-N1,N3-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-
  • 5-(N-2-3-DIHYDROXYPROPYL-ACETMIDO)-2,4,6-TRIIODO-N,N'-bis-(2,3-DIHYDROXYPROPYL)-ISOPHTHALAMIDE
  • 5-[acetyl(2,3-dihydroxypropyl)amino]-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide
  • 5-[acetyl(2,3-dihydroxypropyl)amino]-N1,N3-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-benzene-1,3-dicarboxamide
  • 5-[N-(2,3-Dihydroxypropyl)acetamido]-2,4,6-triiodo-N,N'-bis(2,3-dihydroxypropyl)isophthalamide
  • Iohexol, Pharmaceutical Secondary Standard; Certified Reference Material
  • Iohexol for peak identification, European Pharmacopoeia (EP) Reference Standard
  • (1Z,3Z)-N'1,N'3-bis(2,3-dihydroxypropyl)-5-(N-(2,3-dihydroxypropyl)acetamido)-2,4,6-triiodoisophthalimidic acid
  • 1,3-Benzenedicarboxamide, 5-(acetyl(2,3-dihydroxypropyl)amino)-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo
  • 1,3-Benzenedicarboxamide, 5-[acetyl(2,3- dihydroxypropyl)amino]-N,N'-bis(2,3-dihydroxypropyl)-2,4,6- triiodo
  • 1-N,3-N-bis(2,3-dihydroxypropyl)-5-(N-(2,3-dihydroxypropyl)acetamido)-2,4,6-triiodobenzene-1,3-dicarboxamide
  • 1-N,3-N-bis(2,3-dihydroxypropyl)-5-[N-(2,3-dihydroxypropyl)acetamido]-2,4,6-triiodobenzene-1,3-dicarboxamide
  • 266-164-2
  • 5-(N-2,3-Dihydroxypropylacetamido)-2,4,6-triiodo-N,N inverted exclamation marka-bis(2,3-dihydroxypropyl)isophthalamide
  • 5-[Acetyl(2,3-dihydroxypropyl)amino]-N,N -bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide
  • 5-[Acetyl(2,3-dihydroxypropyl)amino]-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide
  • 5-[n-(2,3-Dihydroxypropyl)acetamido]-2,4,6-triiodo-N,N'-bis(2,3-dihydroxypropyl)isophthalamidesolution
  • 928623-33-0
  • Iohexol; 5-[Acetyl(2,3-dihydroxypropyl)amino]-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide; 1,3-Benzenedicarboxamide, 5-[acetyl(2,3-dihydroxypropyl)amino]-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo- (9CI); 5-(N-2,3-Dihydroxypropylacetamido)-2,4,6-triiodo-N,N'-bis(2,3-dihydroxypropyl)isophthalamide.; Accudenz; Accupaque 300; Exypaque; Histodenz; Iopaque 240; Iopaque 300; Ioverin 350; Nycodenz; Omnipaque; Omnipaque 140; Omnipaque 240; Omnipaque 300; Omnipaque 350; Omnipaque R
  • IOX
  • N,N -Bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-[acetyl(2,3-dihydroxypropyl)amino]isophthalamide
  • N,N -Bis(2,3-dihydroxypropyl)-5-[acetyl(2,3-dihydroxypropyl)amino]-2,4,6-triiodo-1,3-benzenedicarboxamide
  • N,N -Bis(2,3-dihydroxypropyl)-5-[acetyl(2,3-dihydroxypropyl)amino]-2,4,6-triiodoisophthalamide
  • n,n'-bis(2,3-dihydroxypropyl)-5-[n-(2,3-dihydroxypropyl)acetamido]-2,4,6-triiodoisophthalamide
  • N~1~,N~3~-Bis(2,3-dihydroxypropyl)-5-[N-(2,3-dihydroxypropyl)acetamido]-2,4,6-triiodobenzene-1,3-dicarboxamide